A
μmol(l
B
AKI pNvaluedkENLd Time pNvalued=d%:%D Age gr. pNvalued=dR:LMEN)W
SerumdCreatinine
Supplemental Figure 1
child infant newborn noAKI AKI
pre PICU kDhr DMhr Rkhr LOhr discharge
)%%
RW
W%
kW
AKI*timedpNvalued=d%:%y Time*Age gr.dpNvaluedd)ENy NotdmeetingdinclusiondcriteriaG
nd=dMdU)%I6
ScreeneddpatientsGdnd=dRL ApproacheddpatientsGdnd=dDO
InformeddconsentdaskedGdnd=dyk InformeddconsentdsignedGdnd=dkR
PatientsdindthedstudyGdnd=dkD DeclinedconsentGdnd=dW
U)W:OyI6
Surgeryddelayeddafterdenddofd recruitmentdphaseGdnd=d)D
Uy%:DyI6
Surgerydcancelleddfordclinical reasonsGdnd=dkdUR:DI6 Withdrawaldofdconsentddbefore
studydstartGdnd=d)dUy:RI6
CompleteddclinicaldfollowNup nd=dkDdU)%%I6 Variable completeness:
OverallGdMD:%LI ClinicalddataGdLy:OOI RoutinedlabddataGdRW:)OI
Variable analysis:
OverallGdMD:%LI ClinicalddataGdLy:OOI RoutinedlabddataGdRW:)OI
CollecteddblooddsamplesG nd=dOMdULD:DI6 Test completeness:
MicroparticlesGd)%%I microRNAGd)%%I
PlateletsdactivationGdMM:kk LeukocytedactivationGd)%%I CreatinineGd)%%I
Test analysis:
MicroparticlesGd)%%I microRNAGd)%%I PlateletsdactivationGdRO:R LeukocytedactivationGdMO:LOI CreatinineGd)%%I
Collecteddurinedsamples nd=dORdULy:)I6 Test completeness:
CreatinineGd)%%I NGALGd)%%I
Variable analysis:
CreatinineGd)%%I NGALGd)%%I
